Literature DB >> 32602128

Diarrhea and altered inflammatory cytokine pattern in severe coronavirus disease 2019: Impact on disease course and in-hospital mortality.

Lei Zhang1, Chaoqun Han1, Shengyan Zhang1, Caihan Duan1, Haitao Shang1, Tao Bai1, Xiaohua Hou.   

Abstract

BACKGROUND AND AIM: Dynamic changes of immunocyte subsets and inflammatory profiles in coronavirus disease 2019 (COVID-19) patients with gastrointestinal symptoms were undetermined.
METHODS: A single-center retrospective analysis of 409 severe, hospitalized COVID-19 patients from 20 January to 29 February 2020 was performed. The longitudinal characteristics of immune inflammatory cytokines in patients with/without diarrhea were analyzed. The relations of diarrhea and immuno-inflammatory factors with illness course and clinical outcomes were further explored.
RESULTS: Diarrhea was more common and more serious with longer duration (4.9 ± 1.5 vs 4.2 ± 1.5 days, P = 0.039) and higher frequency (5.5 ± 2.1 vs 4.0 ± 2.0 times/day, P = 0.001) in deceased patients than in the survivors. Also, diarrhea patients were more inclined to develop multi-organ damage: survivors have longer illness course (media 41.0 vs 36.0 days, P = 0.052) and hospital stays (media 27.0 vs 23.0 days, P = 0.041), and the deceased patients had higher mortality (33.0% vs 22.6%, P = 0.045) and earlier death (media 20.0 vs 25.0 days, P = 0.038). Progressively, neutrophilia and lymphopenia, especially the declined CD8+ T cells, were demonstrated in diarrhea patients relative to the non-diarrhea cases. The inflammatory cytokines including IL-6, IL-10, and TNF-α were intensively increased in patients with diarrhea. The multivariable logistic analysis showed longer duration of diarrhea (P = 0.036), higher neutrophil counts (P = 0.011), and lower lymphocyte counts (P < 0.001) were independent risk factors of in-hospital death. The proportional hazards model indicated that longer duration of diarrhea (P = 0.002), higher frequency of diarrhea (P = 0.058), higher neutrophil counts (P = 0.001), lower lymphocyte counts (P = 0.035), and decreased proportion of CD8+ T cells (P < 0.001) were independently associated with longer illness course of the survivors.
CONCLUSIONS: Diarrhea patients were more likely to present with neutrophilia, lymphopenia, and cytokine storm and to develop multi-organ damage. The inflammatory patterns were independent factors associated with illness course of the survivors and in-hospital death of severe COVID-19.
© 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Coronavirus disease 2019; Diarrhea; Digestive system; Immuno-inflammatory; SARS-CoV-2

Year:  2020        PMID: 32602128     DOI: 10.1111/jgh.15166

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  18 in total

Review 1.  SARS-CoV-2-associated gastrointestinal and liver diseases: what is known and what is needed to explore.

Authors:  Dina Sweed; Eman Abdelsameea; Esraa A Khalifa; Heba Abdallah; Heba Moaz; Inas Moaz; Shimaa Abdelsattar; Nadine Abdel-Rahman; Asmaa Mosbeh; Hussein A Elmahdy; Eman Sweed
Journal:  Egypt Liver J       Date:  2021-07-31

Review 2.  COVID-19 induces gastrointestinal symptoms and affects patients' prognosis.

Authors:  Shuxun Jin; Xiaofeng Lu; Chaoyang Xu
Journal:  J Int Med Res       Date:  2022-10       Impact factor: 1.573

3.  Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves.

Authors:  Rami M Elshazli; Adam Kline; Abdelaziz Elgaml; Mohamed H Aboutaleb; Mohamed M Salim; Mahmoud Omar; Ruhul Munshi; Nicholas Mankowski; Mohammad H Hussein; Abdallah S Attia; Eman A Toraih; Ahmad Settin; Mary Killackey; Manal S Fawzy; Emad Kandil
Journal:  J Med Virol       Date:  2021-02-23       Impact factor: 20.693

Review 4.  Gastrointestinal manifestations and possible mechanisms of COVID-19 in different periods.

Authors:  Meng Meng Zhang; Lu Ni Chen; Jia Ming Qian
Journal:  J Dig Dis       Date:  2021-12-12       Impact factor: 3.366

Review 5.  Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19.

Authors:  Hao Zhang; Bo Shao; Qin Dang; Zhuang Chen; Quanbo Zhou; Hong Luo; Weitang Yuan; Zhenqiang Sun
Journal:  Front Immunol       Date:  2021-11-10       Impact factor: 7.561

Review 6.  Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications.

Authors:  Jamal Majidpoor; Keywan Mortezaee
Journal:  Biomed Pharmacother       Date:  2021-11-12       Impact factor: 7.419

7.  Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis.

Authors:  Farha Musharrat Noor; Md Momin Islam
Journal:  J Community Health       Date:  2020-12

8.  Outcomes in Patients With COVID-19 Disease and High Oxygen Requirements.

Authors:  Geurys Rojas-Marte; Arsalan Talib Hashmi; Mazin Khalid; Nnamdi Chukwuka; Joshua Fogel; Alejandro Munoz-Martinez; Samantha Ehrlich; Maham Akbar Waheed; Dikshya Sharma; Shaurya Sharma; Awais Aslam; Sabah Siddiqui; Chirag Agarwal; Yuri Malyshev; Carlos Henriquez-Felipe; Jacob Shani
Journal:  J Clin Med Res       Date:  2021-01-12

Review 9.  Twelve Months with COVID-19: What Gastroenterologists Need to Know.

Authors:  Giulia Concas; Michele Barone; Ruggiero Francavilla; Fernanda Cristofori; Vanessa Nadia Dargenio; Rossella Giorgio; Costantino Dargenio; Vassilios Fanos; Maria Antonietta Marcialis
Journal:  Dig Dis Sci       Date:  2021-07-31       Impact factor: 3.487

Review 10.  Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations.

Authors:  Pedro A Pousa; Tamires S C Mendonça; Eduardo A Oliveira; Ana Cristina Simões-E-Silva
Journal:  J Pediatr (Rio J)       Date:  2020-09-22       Impact factor: 2.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.